• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物递送至视网膜光感受器。

Drug delivery to retinal photoreceptors.

机构信息

InoCure s.r.o., Prague, Czech Republic.

Lund University, Faculty of Medicine, Department of Clinical Sciences Lund, Ophthalmology, Lund, Sweden.

出版信息

Drug Discov Today. 2019 Aug;24(8):1637-1643. doi: 10.1016/j.drudis.2019.03.004. Epub 2019 Mar 13.

DOI:10.1016/j.drudis.2019.03.004
PMID:30877076
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6715772/
Abstract

The photoreceptors of the retina are afflicted by diseases that still often lack satisfactory treatment options. Although suitable drugs might be available in some cases, the delivery of these compounds into the eye and across the blood-retinal barrier remains a significant challenge for therapy development. Here, we review the routes of drug administration to the retina and highlight different options for drug delivery to the photoreceptor cells.

摘要

视网膜的感光细胞易患一些疾病,而这些疾病的治疗方法往往仍不尽如人意。尽管在某些情况下可能有合适的药物,但这些化合物进入眼睛并穿过血视网膜屏障仍然是治疗开发的一个重大挑战。在这里,我们回顾了药物向视网膜的给药途径,并强调了向光感受器细胞给药的不同选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8312/6715772/08fd7d968a8e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8312/6715772/fe2c5db50b1e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8312/6715772/08fd7d968a8e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8312/6715772/fe2c5db50b1e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8312/6715772/08fd7d968a8e/gr2.jpg

相似文献

1
Drug delivery to retinal photoreceptors.药物递送至视网膜光感受器。
Drug Discov Today. 2019 Aug;24(8):1637-1643. doi: 10.1016/j.drudis.2019.03.004. Epub 2019 Mar 13.
2
Periocular routes for retinal drug delivery.视网膜药物递送的眼周途径。
Expert Opin Drug Deliv. 2004 Nov;1(1):99-114. doi: 10.1517/17425247.1.1.99.
3
Novel approaches to retinal drug delivery.视网膜药物递送的新方法。
Expert Opin Drug Deliv. 2007 Jul;4(4):371-88. doi: 10.1517/17425247.4.4.371.
4
Subcutaneous delivery of tauroursodeoxycholic acid rescues the cone photoreceptors in degenerative retina: A promising therapeutic molecule for retinopathy.牛磺熊去氧胆酸经皮给药可挽救变性视网膜中的视锥细胞:一种用于治疗视网膜病变的有前途的治疗分子。
Biomed Pharmacother. 2019 Sep;117:109021. doi: 10.1016/j.biopha.2019.109021. Epub 2019 Jul 4.
5
Recent developments in liposomal drug delivery systems for the treatment of retinal diseases.近年来用于治疗视网膜疾病的脂质体药物传递系统的新进展。
Drug Discov Today. 2019 Aug;24(8):1660-1668. doi: 10.1016/j.drudis.2019.04.004. Epub 2019 Apr 5.
6
Intravitreal nanoparticles for retinal delivery.玻璃体腔递药纳米粒
Drug Discov Today. 2019 Aug;24(8):1510-1523. doi: 10.1016/j.drudis.2019.05.005. Epub 2019 May 16.
7
Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling.经巩膜给药至眼后段:药代动力学建模的前景
Adv Drug Deliv Rev. 2006 Nov 15;58(11):1164-81. doi: 10.1016/j.addr.2006.07.025. Epub 2006 Sep 16.
8
Drug delivery to the posterior segment of the eye.药物递送至眼部后节。
Drug Discov Today. 2011 Mar;16(5-6):270-7. doi: 10.1016/j.drudis.2010.12.004. Epub 2010 Dec 15.
9
Intravitreal drug delivery in retinal disease: are we out of our depth?视网膜疾病的玻璃体内药物递送:我们是否力不从心?
Expert Opin Drug Deliv. 2014 Oct;11(10):1575-90. doi: 10.1517/17425247.2014.927864. Epub 2014 Jun 14.
10
What Can Pharmacological Models of Retinal Degeneration Tell Us?视网膜变性的药理学模型能告诉我们什么?
Curr Mol Med. 2017;17(2):100-107. doi: 10.2174/1566524017666170331162048.

引用本文的文献

1
Nanovesicular Drug Delivery Systems for Rare Ocular Diseases: Advances, Challenges, and Future Directions.用于罕见眼科疾病的纳米囊泡给药系统:进展、挑战与未来方向
AAPS PharmSciTech. 2025 Jul 23;26(7):197. doi: 10.1208/s12249-025-03159-8.
2
H105A peptide eye drops promote photoreceptor survival in murine and human models of retinal degeneration.H105A肽眼药水可促进视网膜变性小鼠和人类模型中的光感受器存活。
Commun Med (Lond). 2025 Mar 21;5(1):81. doi: 10.1038/s43856-025-00789-8.
3
Nanotherapy for Neural Retinal Regeneration.用于神经视网膜再生的纳米疗法。

本文引用的文献

1
Topical Drug Delivery to the Posterior Segment of the Eye: Addressing the Challenge of Preclinical to Clinical Translation.眼部后节局部药物递送:解决从临床前到临床转化的挑战。
Pharm Res. 2018 Oct 29;35(12):245. doi: 10.1007/s11095-018-2519-x.
2
SUPRACHOROIDAL INJECTION OF TRIAMCINOLONE ACETONIDE, CLS-TA, FOR MACULAR EDEMA DUE TO NONINFECTIOUS UVEITIS: A Randomized, Phase 2 Study (DOGWOOD).经巩膜睫状突注射曲安奈德(CLS-TA)治疗非感染性葡萄膜炎相关黄斑水肿的随机、2 期研究(DOGWOOD)
Retina. 2019 Oct;39(10):1880-1888. doi: 10.1097/IAE.0000000000002279.
3
Combination of cGMP analogue and drug delivery system provides functional protection in hereditary retinal degeneration.
Adv Sci (Weinh). 2025 Jun;12(24):e2409854. doi: 10.1002/advs.202409854. Epub 2025 Jan 14.
4
H105A peptide eye drops promote photoreceptor survival in murine and human models of retinal degeneration.H105A肽眼药水可促进视网膜变性小鼠和人类模型中的光感受器存活。
bioRxiv. 2024 Jul 16:2024.07.10.602890. doi: 10.1101/2024.07.10.602890.
5
New Improved cGMP Analogues to Target Rod Photoreceptor Degeneration.新型改良 cGMP 类似物靶向 rod 光感受器变性。
J Med Chem. 2024 May 23;67(10):8396-8405. doi: 10.1021/acs.jmedchem.4c00586. Epub 2024 Apr 30.
6
Expanding the phenotype of : a range of macular dystrophies as the major clinical manifestations in patients with a dominant splicing variant.扩大:一系列黄斑营养不良作为显性剪接变异患者主要临床表现的表型。
Front Cell Dev Biol. 2023 Jul 21;11:1197744. doi: 10.3389/fcell.2023.1197744. eCollection 2023.
7
Inherited Retinal Degeneration: Towards the Development of a Combination Therapy Targeting Histone Deacetylase, Poly (ADP-Ribose) Polymerase, and Calpain.遗传性视网膜变性:开发靶向组蛋白去乙酰化酶、多聚(ADP-核糖)聚合酶和钙蛋白酶的联合治疗方法。
Biomolecules. 2023 Mar 23;13(4):581. doi: 10.3390/biom13040581.
8
Novel Approaches in the Drug Development and Delivery Systems for Age-Related Macular Degeneration.年龄相关性黄斑变性药物研发与递送系统的新方法
Life (Basel). 2023 Feb 17;13(2):568. doi: 10.3390/life13020568.
9
Lutein nanodisks protect human retinal pigment epithelial cells from UV light-induced damage.叶黄素纳米盘可保护人视网膜色素上皮细胞免受紫外线诱导的损伤。
Front Nanotechnol. 2022;4. doi: 10.3389/fnano.2022.955022. Epub 2022 Aug 15.
10
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles.用于视网膜靶向杂化纳米颗粒控释的可注射水凝胶储库系统的优化
Pharmaceutics. 2022 Dec 21;15(1):25. doi: 10.3390/pharmaceutics15010025.
环鸟苷酸类似物与药物递送系统的联合应用为遗传性视网膜退行性病变提供了功能保护。
Proc Natl Acad Sci U S A. 2018 Mar 27;115(13):E2997-E3006. doi: 10.1073/pnas.1718792115. Epub 2018 Mar 12.
4
Manipulating ocular endothelial tight junctions: Applications in treatment of retinal disease pathology and ocular hypertension.调控眼内皮层紧密连接:在视网膜疾病病理学和眼高压治疗中的应用。
Prog Retin Eye Res. 2018 Jan;62:120-133. doi: 10.1016/j.preteyeres.2017.09.003. Epub 2017 Sep 22.
5
Subretinal Injection for Gene Therapy Does Not Cause Clinically Significant Outer Nuclear Layer Thinning in Normal Primate Foveae.视网膜下注射基因治疗不会导致正常灵长类动物黄斑中心凹外核层出现具有临床意义的变薄。
Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):4155-4160. doi: 10.1167/iovs.17-22402.
6
The Economic Impact of Blindness in Europe.欧洲失明问题的经济影响。
Ophthalmic Epidemiol. 2017 Aug;24(4):239-247. doi: 10.1080/09286586.2017.1281426. Epub 2017 Jun 30.
7
Physical Activity and Age-related Macular Degeneration: A Systematic Literature Review and Meta-analysis.身体活动与年龄相关性黄斑变性:一项系统文献综述和荟萃分析
Am J Ophthalmol. 2017 Aug;180:29-38. doi: 10.1016/j.ajo.2017.05.016. Epub 2017 May 24.
8
Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye.环糊精与眼部前后节的局部给药
Int J Pharm. 2017 Oct 15;531(2):413-423. doi: 10.1016/j.ijpharm.2017.04.010. Epub 2017 Apr 6.
9
Enhanced ocular efficacy of topically-delivered dorzolamide with nanostructured mucoadhesive microparticles.纳米结构黏膜黏附型微孔载多佐胺滴眼剂增强眼部疗效。
Int J Pharm. 2017 Apr 30;522(1-2):66-73. doi: 10.1016/j.ijpharm.2017.02.035. Epub 2017 Feb 16.
10
Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo.谷胱甘肽结合物在体外和体内均能剂量依赖性地增加脑特异性脂质体药物递送。
Drug Discov Today Technol. 2016 Jun;20:59-69. doi: 10.1016/j.ddtec.2016.09.003. Epub 2016 Oct 13.